These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32344508)

  • 1. Membrane Phospholipids and Polyphosphates as Cofactors and Binding Molecules of SERPINA12 (vaspin).
    Tindall CA; Dommel S; Riedl V; Ulbricht D; Hanke S; Sträter N; Heiker JT
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32344508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic Residues of β-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12).
    Ulbricht D; Oertwig K; Arnsburg K; Saalbach A; Pippel J; Sträter N; Heiker JT
    J Biol Chem; 2017 Jan; 292(3):994-1004. PubMed ID: 27941022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique serpin P1' glutamate and a conserved β-sheet C arginine are key residues for activity, protease recognition and stability of serpinA12 (vaspin).
    Ulbricht D; Pippel J; Schultz S; Meier R; Sträter N; Heiker JT
    Biochem J; 2015 Sep; 470(3):357-67. PubMed ID: 26199422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation of human vaspin (SERPINA12) and its impact on serpin activity, heparin binding and thermal stability.
    Oertwig K; Ulbricht D; Hanke S; Pippel J; Bellmann-Sickert K; Sträter N; Heiker JT
    Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1188-1194. PubMed ID: 28668641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaspin inhibits kallikrein 7 by serpin mechanism.
    Heiker JT; Klöting N; Kovacs P; Kuettner EB; Sträter N; Schultz S; Kern M; Stumvoll M; Blüher M; Beck-Sickinger AG
    Cell Mol Life Sci; 2013 Jul; 70(14):2569-83. PubMed ID: 23370777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New lipid interaction partners stimulate the inhibition of activated protein C by cell-penetrating protein C inhibitor.
    Wahlmüller FC; Sokolikova B; Rieger D; Geiger M
    Thromb Haemost; 2014 Jan; 111(1):41-52. PubMed ID: 24136361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin.
    Ulbricht D; Tindall CA; Oertwig K; Hanke S; Sträter N; Heiker JT
    Biol Chem; 2018 Sep; 399(9):1079-1084. PubMed ID: 29494334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaspin (serpinA12) in obesity, insulin resistance, and inflammation.
    Heiker JT
    J Pept Sci; 2014 May; 20(5):299-306. PubMed ID: 24596079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of cleaved vaspin (serpinA12).
    Pippel J; Kuettner EB; Ulbricht D; Daberger J; Schultz S; Heiker JT; Sträter N
    Biol Chem; 2016 Jan; 397(2):111-23. PubMed ID: 26529565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms of Vaspin Action - From Adipose Tissue to Skin and Bone, from Blood Vessels to the Brain.
    Weiner J; Zieger K; Pippel J; Heiker JT
    Adv Exp Med Biol; 2019; 1111():159-188. PubMed ID: 30051323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRP1 is the cell-surface endocytosis receptor for vaspin in adipocytes.
    Tindall CA; Möhlis K; Rapöhn I; Dommel S; Riedl V; Schneekönig M; Höfling C; Roßner S; Stichel J; Beck-Sickinger AG; Weiner J; Heiker JT
    FEBS J; 2024 May; 291(10):2134-2154. PubMed ID: 37921063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the binding site of C1-inhibitor for polyanion cofactors.
    Hor L; Pan J; Whisstock JC; Pike RN; Wijeyewickrema LC
    Mol Immunol; 2020 Oct; 126():8-13. PubMed ID: 32717572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex.
    Nakatsuka A; Wada J; Iseda I; Teshigawara S; Higashio K; Murakami K; Kanzaki M; Inoue K; Terami T; Katayama A; Hida K; Eguchi J; Horiguchi CS; Ogawa D; Matsuki Y; Hiramatsu R; Yagita H; Kakuta S; Iwakura Y; Makino H
    Diabetes; 2012 Nov; 61(11):2823-32. PubMed ID: 22837305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaspin in obesity and diabetes: pathophysiological and clinical significance.
    Blüher M
    Endocrine; 2012 Apr; 41(2):176-82. PubMed ID: 22139797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Vaspin (SERPINA12) Expression and Function in Endocrine Cells.
    Kurowska P; Mlyczyńska E; Dawid M; Jurek M; Klimczyk D; Dupont J; Rak A
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity.
    Li Q; Chen R; Moriya J; Yamakawa J; Sumino H; Kanda T; Takahashi T
    J Int Med Res; 2008; 36(4):625-9. PubMed ID: 18652756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a major heparin-binding site in kallistatin.
    Chen VC; Chao L; Pimenta DC; Bledsoe G; Juliano L; Chao J
    J Biol Chem; 2001 Jan; 276(2):1276-84. PubMed ID: 11016932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.